AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glymiz-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Isomer Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glymiz-M1 Tablet SR

Diabexe Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo SR should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continued use is crucial, even with controlled glucose levels, as premature discontinuation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before using this medication if pregnant or breastfeeding. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Glymiz-M1 Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glymiz-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glymiz-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glymiz-M1 Tablet SR should be administered with a meal.

Common Side effects of Glymiz-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glymiz-M1 Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for Glymiz-M1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glymiz-M1 Tablet SR works:

Glymiz-M1 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glymiz-M1 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glymiz-M1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Glymiz-M1 SR tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.

KidneyKidneyCAUTION

Exercise caution when prescribing Glymiz-M1 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Glymiz-M1 SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glymiz-M1 SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is generally recommended for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glymiz-M1 Tablet SR :

Should you forget a Glymiz-M1 Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glymiz-M1 Tablet SR

LabelValue
Developing Good Habits No.
Type of Therapy Diabetes Management

FAQs on Glymiz-M1 Tablet SR

Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and keep it out of reach of children, pets, and others.
Glymiz-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glymiz-M1 Tablet SR and seek immediate medical attention.
Glymiz-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glymiz-M1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glymiz-M1 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake is recommended annually by some researchers.
Glymiz-M1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glymiz-M1 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glymiz-M1 Tablet SR
65
MRP 79
17% off